1. Home
  2. BIVI vs ETS Comparison

BIVI vs ETS Comparison

Compare BIVI & ETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • ETS
  • Stock Information
  • Founded
  • BIVI 2013
  • ETS 2020
  • Country
  • BIVI United States
  • ETS United States
  • Employees
  • BIVI N/A
  • ETS N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • ETS Trucking Freight/Courier Services
  • Sector
  • BIVI Health Care
  • ETS Industrials
  • Exchange
  • BIVI Nasdaq
  • ETS Nasdaq
  • Market Cap
  • BIVI 14.2M
  • ETS 14.7M
  • IPO Year
  • BIVI N/A
  • ETS 2025
  • Fundamental
  • Price
  • BIVI $1.91
  • ETS $0.77
  • Analyst Decision
  • BIVI
  • ETS
  • Analyst Count
  • BIVI 0
  • ETS 0
  • Target Price
  • BIVI N/A
  • ETS N/A
  • AVG Volume (30 Days)
  • BIVI 184.5K
  • ETS 175.4K
  • Earning Date
  • BIVI 11-12-2025
  • ETS 10-14-2025
  • Dividend Yield
  • BIVI N/A
  • ETS N/A
  • EPS Growth
  • BIVI N/A
  • ETS N/A
  • EPS
  • BIVI N/A
  • ETS N/A
  • Revenue
  • BIVI N/A
  • ETS $2,585,885.00
  • Revenue This Year
  • BIVI N/A
  • ETS N/A
  • Revenue Next Year
  • BIVI N/A
  • ETS N/A
  • P/E Ratio
  • BIVI N/A
  • ETS N/A
  • Revenue Growth
  • BIVI N/A
  • ETS 6.59
  • 52 Week Low
  • BIVI $1.42
  • ETS $0.75
  • 52 Week High
  • BIVI $75.00
  • ETS $4.23
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 46.41
  • ETS N/A
  • Support Level
  • BIVI $1.81
  • ETS N/A
  • Resistance Level
  • BIVI $2.07
  • ETS N/A
  • Average True Range (ATR)
  • BIVI 0.13
  • ETS 0.00
  • MACD
  • BIVI 0.03
  • ETS 0.00
  • Stochastic Oscillator
  • BIVI 37.99
  • ETS 0.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About ETS Elite Express Holding Inc. Class A Common Stock

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

Share on Social Networks: